Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA
Read More 5 minute read Pharma Industry News Can Calluna Pharma’s CAL101 finally change the game for idiopathic pulmonary fibrosis patients? Calluna Pharma begins Phase 2 AURORA trial of CAL101 in idiopathic pulmonary fibrosis, targeting S100A4 for a novel antifibrotic approach. byPallavi MadhirajuAugust 26, 2025